GC3102C

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3102C, covering 2016-01-15 to 2016-01-15. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults [Phase 3]

See pricing